We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
(+10%)
Cap. Flow
+$798M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.3M |
| 2 |
Amazon
AMZN
|
+$50M |
| 3 |
Tesla
TSLA
|
+$30.5M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$26.6M |
| 5 |
EPAM Systems
EPAM
|
+$26.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$39.1M |
| 2 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$31.2M |
| 3 |
XEC
CIMAREX ENERGY CO
XEC
|
+$23.4M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$21.9M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.54% |
| 2 | Financials | 13.15% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Aveanna Healthcare
AVAH
$2.07B
| $226K | ﹤0.01% |
30,535
-664
| -2% | -$4.83K |
|
2802
Kopin
KOPN
$791M
| $225K | ﹤0.01% |
55,109
-1,659
| -3% | -$8.43K |
|
2803
Teekay
TK
$985M
| $225K | ﹤0.01% |
71,682
-369
| -0.5% | -$1.27K |
|
2804
Korro Bio
KRRO
$195M
| $224K | ﹤0.01% |
874
-23
| -3% | -$6.99K |
|
2805
INNOVATE Corp
VATE
$165M
| $224K | ﹤0.01% |
6,048
-171
| -3% | -$6.8K |
|
2806
Avita Medical
RCEL
$240M
| $223K | ﹤0.01% |
18,587
-420
| -2% | -$6.41K |
|
2807
Kodak
KODK
$983M
| $222K | ﹤0.01% |
47,377
+5,469
| +13% | +$34.4K |
|
2808
Algonquin Power & Utilities
AQN
$4.42B
| $220K | ﹤0.01% |
15,212
-28
| -0.2% | -$401 |
|
|
TRML
2809
DELISTED
Tourmaline Bio
TRML
| $219K | ﹤0.01% |
+1,430
| New | +$212K |
|
2810
Q32 Bio
QTTB
$464M
| $219K | ﹤0.01% |
3,341
+7
| +0.2% | +$679 |
|
2811
Janux Therapeutics
JANX
$967M
| $218K | ﹤0.01% |
11,037
-73
| -0.7% | -$1.53K |
|
2812
Global Water Resources
GWRS
$219M
| $217K | ﹤0.01% |
12,707
-229
| -2% | -$4.16K |
|
2813
Blue Owl Capital
OBDC
$5.74B
| $217K | ﹤0.01% |
15,333
+19
| +0.1% | +$272 |
|
|
SYRS
2814
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $217K | ﹤0.01% |
6,666
-11
| -0.2% | -$445 |
|
|
SURF
2815
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $217K | ﹤0.01% |
45,443
-845
| -2% | -$5.45K |
|
2816
Neurogene
NGNE
$712M
| $216K | ﹤0.01% |
2,237
-30
| -1% | -$3.65K |
|
2817
Vor Biopharma
VOR
$1.28B
| $213K | ﹤0.01% |
917
+147
| +19% | +$42.4K |
|
2818
Atossa Therapeutics
ATOS
$23.5M
| $211K | ﹤0.01% |
8,775
-224
| -2% | -$8.2K |
|
|
PSTX
2819
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $211K | ﹤0.01% |
30,927
-516
| -2% | -$3.52K |
|
|
SIEN
2820
DELISTED
Sientra, Inc.
SIEN
| $210K | ﹤0.01% |
5,730
-141
| -2% | -$6.83K |
|
|
USX
2821
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $210K | ﹤0.01% |
35,775
-738
| -2% | -$5.54K |
|
2822
Concrete Pumping Holdings
BBCP
$491M
| $208K | ﹤0.01% |
25,332
-567
| -2% | -$4.85K |
|
2823
Heritage Insurance Holdings
HRTG
$991M
| $207K | ﹤0.01% |
35,159
-1,146
| -3% | -$7.55K |
|
|
CMBM
2824
DELISTED
Cambium Networks
CMBM
| $206K | ﹤0.01% |
8,021
+658
| +9% | +$19K |
|
2825
KVH Industries
KVHI
$157M
| $206K | ﹤0.01% |
22,438
-598
| -3% | -$6K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2021 Portfolio in Review
As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
- RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
- RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
- RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
- RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.
Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.